You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBeAg Positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Virus - Chronic Active Trial (Fumarate, Tenofovir Disoproxil)

Not yet recruiting
  • Hepatitis B Virus - Chronic Active
  • Fumarate, Tenofovir Disoproxil
  • (no location specified)
May 28, 2022

Hepatitis B, Chronic Trial in Beijing (Hepalatide 2.1mg, Hepalatide 4.2mg, Hepalatide 6.3mg)

Recruiting
  • Hepatitis B, Chronic
  • Hepalatide 2.1mg
  • +6 more
  • Beijing, Beijing, China
    The fifth medical center of PLA
Nov 23, 2021

TAF for 48 Weeks in HBeAg Positive CHB Patients

Recruiting
  • Chronic Hepatitis B
  • Tenofovir Alafenamide 25 MG [Vemlidy]
  • Shanghai, China
  • +2 more
Sep 5, 2021

Chronic Hepatitis Trial in Hangzhou, Shanghai (Group A, TDF, Group B:TDF then TDF and Peginterferon alfa-2a, Group C:TDF and

Recruiting
  • Chronic Hepatitis
  • Group A, TDF
  • +2 more
  • Hangzhou, China
  • +7 more
Sep 21, 2021

CHRONIC HEPATITIS B Trial in Hô` Chi´ Minh (CTH Chronic Hepatitis B)

Approved for marketing
  • CHRONIC HEPATITIS B
  • CTH Chronic Hepatitis B
  • Hồ Chí Minh, Ho Chi Minh City, Vietnam
    Saigon Biopharma Company Limited
Oct 6, 2021

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Chronic Hepatitis B Trial in Guangzhou (TDF, Tenofovir Disoproxil Fumarate 300 MG)

Recruiting
  • Chronic Hepatitis B
  • TDF
  • Tenofovir Disoproxil Fumarate 300 MG
  • Guangzhou, China
    Chaoshuang Lin
Jan 8, 2021

HBeAg Positive Chronic Hepatitis B Trial in Beijing (NAs+IFN-a)

Not yet recruiting
  • HBeAg Positive Chronic Hepatitis B
  • Beijing, Beijing, China
    Min Zhang
Sep 28, 2020

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Chronic HBV Infection Trial in China (HH-003 injection, Placebo)

Completed
  • Chronic HBV Infection
  • HH-003 injection
  • Placebo
  • Beijing, Beijing, China
  • +10 more
Sep 14, 2022

Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])

Completed
Has Results
  • Hepatitis B, Chronic
  • peginterferon alfa-2a [Pegasys]
  • San Francisco, California
  • +38 more
Oct 26, 2022

Hepatitis B, Interferon Trial (Interferon, Interferon+resveratrol)

Completed
  • Hepatitis B
  • Interferon
  • (no location specified)
Oct 10, 2020

HBV, Chronic HBV Infections Trial in China (TAF, TDF, TAF Placebo)

Active, not recruiting
Has Results
  • HBV
  • Chronic HBV Infections
  • Beijing, China
  • +24 more
Mar 17, 2022

Chronic Hepatitis B Trial in Worldwide (ABI-H0731, SOC ETV, Placebo Oral Tablet)

Completed
Has Results
  • Chronic Hepatitis B
  • Coronado, California
  • +11 more
Jan 8, 2021

Predictive Model for Prognosis of Chronic HBV Infection Mothers

Recruiting
  • Hepatitis B, Chronic
  • Age, BMI,Baseline HBV DNA, Baseline HBeAg level, Baseline HBsAg level, Antiviral treatment, Serum ALT level
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 20, 2021

Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)

Recruiting
  • Hepatitis B, Chronic
  • IMC-I109V-101 Single Ascending Dose
  • IMC-I109V-101 Multiple Ascending Doses
  • Los Angeles, California
  • +19 more
May 10, 2023

Metabolic Syndrome on Antiviral Response in People With Chronic

Not yet recruiting
  • Chronic Hepatitis b
    • (no location specified)
    Jan 21, 2023

    Hepatitis B, Chronic Trial in Changchun (drug, other, combination product)

    Not yet recruiting
    • Hepatitis B, Chronic
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Jul 29, 2022

    Long-term Benefit in Chronic Hepatitis B Patients After Standard

    Completed
    • Hepatitis B
    • Peginterferon Alfa-2B
    • Peginterferon Alfa-2A
    • Beijing, Beijing, China
    • +27 more
    Apr 11, 2021

    Pediatric Immuno-Tolerant Chronic Hepatitis B Trial in Worldwide (Entecavir, Lamivudine, Pegylated Interferon Alfa-2A)

    Completed
    Has Results
    • Pediatric Immuno-Tolerant Chronic Hepatitis B
    • Kansas City, Missouri
    • +24 more
    Aug 21, 2020

    Hepatitis B, Chronic Trial in Japan (Tenofovir Disoproxil Fumarate)

    Completed
    Has Results
    • Hepatitis B, Chronic
    • Tenofovir Disoproxil Fumarate
    • Aichi, Japan
    • +17 more
    Jul 22, 2020

    Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

    Active, not recruiting
    • Chronic Hepatitis B
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Apr 20, 2023

    Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

    Recruiting
    • Chronic HBV Infection
    • Peginterferon alfa-2b combined and ETV
    • Shenzhen, China
      Shenzhen Third People Hospital
    Mar 19, 2023

    After Long-Term Antiviral Treatment for Chronic Hepatitis B

    Completed
    • Chronic Hepatitis B e Antigen Positive
    • Chronic Hepatitis B e Antigen Negative
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      HBV, Chronic HBV Infection Trial in Worldwide (TAF, TDF, TAF Placebo)

      Active, not recruiting
      Has Results
      • HBV
      • Chronic HBV Infection
      • Los Angeles, California
      • +159 more
      Mar 17, 2022